Curve Therapeutics

About:

Curve develops an innovative screening platform.

Website: https://www.curvetx.com/

Top Investors: Pfizer Venture Investments, Advent Life Sciences, British Patient Capital, Columbus Venture Partners, Epidarex Capital

Description:

Curve has developed an innovative screening platform that is transforming the discovery of first-in-class therapeutics. The platform allows functional screening of diverse, genetically encoded Microcycle™ libraries against a broad range of disease-associated targets that are present in their native conformation inside a mammalian cell. Curve is deploying this platform to build a pipeline of novel cancer drugs.

Total Funding Amount:

40.5M GBP

Headquarters Location:

Southampton, Southampton, United Kingdom

Founded Date:

2019-01-01

Contact Email:

info(AT)curvetx.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2024-02-27

IPO Status:

Private

Industries:

© 2025 bioDAO.ai